Targeted Nanoparticles for PROTAC-Mediated JAK1/JAK2 Degradation for Bladder Cancer Treatment. Ding W, Zhang X, Wu H, Zhou C, et al. Int J Nanomedicine 2026;21:616713.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ding W, Zhang X, Wu H, Zhou C, et al. Targeted Nanoparticles for PROTAC-Mediated JAK1/JAK2 Degradation for Bladder Cancer Treatment. Int J Nanomedicine 2026;21:616713.
PMID: 42802799